Delivery Order SPE2DB20D3101-SPE2DB24FQUX6

Award Date 11/20/23
Potential Completion Date 11/21/23
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,845.56 firm fixed-price delivery order is for the provision of "MUCUS RELIEF ER 600 MG TABLET 500S" and has an ultimate completion date of December 5, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division,...
This federal contract award, valued at $4,235.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of "MUCUS RELIEF ER 600 MG TABLET 500S", a pharmaceutical product, with a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,142.68 and a period of performance through November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
This federal contract award, valued at $1,891.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566422707 - MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $3,655.53 firm fixed-price delivery order for the supply of "MUCUS RLF DM ER 600-30 MG TAB 20S", a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
The federal contract award SPE2DB20D3103|SPE2DB25FM9H6, valued at $1,088.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "MUCUS RELIEF ER 600 MG TABLET 500S" and has a firm fixed price pricing type with an ultimate completion date of March 5, 2025. This contract award is part of Amerisourcebergen's larger Indefinite Delivery...
This federal contract award, valued at $2,520.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S, a medical product, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.77, is for the delivery of MUCUS RLF DM ER 600-30 MG TAB 20S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $3,327.51 firm fixed price delivery order (SPE2DB24FJRK7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of 4565461978 MUCUS RELIEF ER 600 MG TABLET 100S. The contract has an ultimate completion date of August 16, 2024. This appears to be a continuation of Amerisourcebergen's broader supply relationship with DLA, as the company holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,200.12, is a delivery order for the supply of "MUCUS RELIEF ER 600 MG TABLET 500S". The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FQUX6
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,852.38 firm fixed-price contract is for the supply of 4562867292 ! MUCUS RELIEF ER 600 MG TABLET 500S.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The DLA, as a defense agency, is the funding source for this contract, which aligns with its mission to support the military's medical needs.

Generated 5/12/25, 10:23 AM